SCHEMBL1992233

SCHEMBL1992233

O=C1NC(=O)C(c2cn(CC3CNCCO3)c3ccccc23)=C1c1c[nH]c2sccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 12/20 0.47
PRKACB P22694 11/20 0.47
PRKACG P22612 10/20 0.47
CAMK2D Q13557 5/20 0.45
CDK4 P11802 4/20 0.42
CCND1 P24385 3/20 0.42
PRKCB P05771 8/20 0.42
PRKCG P05129 7/20 0.42
PRKCA P17252 7/20 0.42
PRKCH P24723 7/20 0.42
PRKCD Q05655 7/20 0.42
PRKCZ Q05513 4/20 0.42
PRKCE Q02156 4/20 0.42
SRC P12931 2/20 0.42
SIRT2 Q8IXJ6 2/20 0.41
PIM1 P11309 3/20 0.41
GSK3B P49841 3/20 0.41
PRKCQ Q04759 3/20 0.41
PRKCI P41743 2/20 0.41
RPS6KA1 Q15418 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994510 0.87 PRKACA (0.48) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1989905 0.85 PRKACA (0.55) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1996935 0.84 CAMK2D (0.45) PRKACACAMK2DPRKCBPRKCGPRKCA
SCHEMBL1992573 0.82 PRKACA (0.46) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1995619 0.78 PRKACA (0.62) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1995640 0.77 PRKACA (0.49) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1992560 0.77 PRKACA (0.56) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1992239 0.76 PRKACA (0.55) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1990219 0.76 PRKACA (0.55) PRKACAPRKACBPRKACGCAMK2DCDK4
SCHEMBL1993579 0.76 PRKACA (0.49) PRKACAPRKACBPRKACGCAMK2DCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKACA 947/4885PRKACB 1285/4885PRKACG 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.